| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An International First: Stakeholder Consensus Statement for Food Allergen Management in Packaged Foods and Food Service for Australia and New Zealand
|
Roche, Ingrid
|
|
|
10 |
8 |
p. 2056-2065
|
artikel
|
| 2 |
A Systematic Review of Aquagenic Urticaria—Subgroups and Treatment Options
|
Rujitharanawong, Chuda
|
|
|
10 |
8 |
p. 2154-2162
|
artikel
|
| 3 |
Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children
|
Banzon, Tina M.
|
|
|
10 |
8 |
p. 2117-2124.e4
|
artikel
|
| 4 |
Children With Food Allergy Are at Risk of Lower Lung Function on High-Pollen Days
|
Idrose, N. Sabrina
|
|
|
10 |
8 |
p. 2144-2153.e10
|
artikel
|
| 5 |
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review
|
Requena, Gema
|
|
|
10 |
8 |
p. 2125-2134
|
artikel
|
| 6 |
CME Activities Calendar
|
|
|
|
10 |
8 |
p. A35-A36
|
artikel
|
| 7 |
CME exam: Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
|
|
|
|
10 |
8 |
p. 1951-1952
|
artikel
|
| 8 |
CME exam: Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022
|
|
|
|
10 |
8 |
p. 1985
|
artikel
|
| 9 |
CME exam: Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
|
|
|
|
10 |
8 |
p. 2013-2014
|
artikel
|
| 10 |
Cover 1
|
|
|
|
10 |
8 |
p. OFC
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
10 |
8 |
p. A28
|
artikel
|
| 12 |
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
|
Valent, Peter
|
|
|
10 |
8 |
p. 1941-1950
|
artikel
|
| 13 |
High SABA Using and Poor Asthma Control: Blaming Poor Adherence or Missing the Phenotype?
|
Hogan, Mary Beth
|
|
|
10 |
8 |
p. 2084-2085
|
artikel
|
| 14 |
Hormonal Effects on Asthma, Rhinitis, and Eczema
|
Weare-Regales, Natalia
|
|
|
10 |
8 |
p. 2066-2073
|
artikel
|
| 15 |
Hospitalization to emergency department visit ratio for pediatric asthma: A population-based study
|
Owotomo, Olusegun
|
|
|
10 |
8 |
p. 2184-2186.e2
|
artikel
|
| 16 |
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease
|
Pitlick, Mitchell M.
|
|
|
10 |
8 |
p. 2187-2190.e1
|
artikel
|
| 17 |
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience
|
Oh, Jessica
|
|
|
10 |
8 |
p. 2176-2177.e1
|
artikel
|
| 18 |
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions
|
Lyons, Jonathan J.
|
|
|
10 |
8 |
p. 1964-1973
|
artikel
|
| 19 |
Inequalities in asthma mortality by ethnicity and race in the United States and Puerto Rico
|
Nazario, Sylvette
|
|
|
10 |
8 |
p. 2178-2180
|
artikel
|
| 20 |
Information for Readers
|
|
|
|
10 |
8 |
p. A29
|
artikel
|
| 21 |
Long-Term Use of Short-Acting β2-Agonists in Patients With Adult-Onset Asthma
|
Vähätalo, Iida
|
|
|
10 |
8 |
p. 2074-2083.e7
|
artikel
|
| 22 |
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
|
Jennings, Susan V.
|
|
|
10 |
8 |
p. 2039-2051
|
artikel
|
| 23 |
Mode of Birth Is Not Associated With Food Allergy Risk in Infants
|
Currell, Anne
|
|
|
10 |
8 |
p. 2135-2143.e3
|
artikel
|
| 24 |
Nasal secretion tissue plasminogen activator: A novel effective predictor of nasal polyp recurrence
|
Chen, Cai-Ling
|
|
|
10 |
8 |
p. 2191-2194.e3
|
artikel
|
| 25 |
Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022
|
Butterfield, J.H.
|
|
|
10 |
8 |
p. 1974-1984
|
artikel
|
| 26 |
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility
|
DeLeon, Samuel
|
|
|
10 |
8 |
p. 2181-2183.e1
|
artikel
|
| 27 |
Original Article Highlights From This Issue
|
|
|
|
10 |
8 |
p. A25-A27
|
artikel
|
| 28 |
Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed
|
van der Meer, Akke-Nynke
|
|
|
10 |
8 |
p. 2093-2098
|
artikel
|
| 29 |
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
|
Valent, Peter
|
|
|
10 |
8 |
p. 1999-2012.e6
|
artikel
|
| 30 |
Practice Notes from the AAAI
|
|
|
|
10 |
8 |
p. A32-A33
|
artikel
|
| 31 |
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
|
Gotlib, Jason
|
|
|
10 |
8 |
p. 2025-2038.e1
|
artikel
|
| 32 |
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers
|
Hashimoto, Simone
|
|
|
10 |
8 |
p. 2099-2108.e6
|
artikel
|
| 33 |
Recent Developments in the Field of Mast Cell Disorders: Classification, Prognostication, and Management
|
Valent, Peter
|
|
|
10 |
8 |
p. 2052-2055
|
artikel
|
| 34 |
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
|
Pyatilova, Polina
|
|
|
10 |
8 |
p. 2015-2024
|
artikel
|
| 35 |
Remission of indolent systemic mastocytosis in the absence of targeted therapy
|
Constantine, Gregory M.
|
|
|
10 |
8 |
p. 2163-2165.e2
|
artikel
|
| 36 |
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate
|
Hartono, Stella P.
|
|
|
10 |
8 |
p. 2172-2175.e1
|
artikel
|
| 37 |
Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2
|
Davila-Fernandez, Galicia
|
|
|
10 |
8 |
p. 2166-2168.e1
|
artikel
|
| 38 |
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
|
Hoermann, Gregor
|
|
|
10 |
8 |
p. 1953-1963
|
artikel
|
| 39 |
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
|
Sotlar, Karl
|
|
|
10 |
8 |
p. 1986-1998.e2
|
artikel
|
| 40 |
Table of Contents
|
|
|
|
10 |
8 |
p. A5-A8, A10, A12, A14, A16
|
artikel
|
| 41 |
The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study
|
Toennesen, Louise Lindhardt
|
|
|
10 |
8 |
p. 2086-2092.e2
|
artikel
|
| 42 |
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review
|
Codispoti, Christopher D.
|
|
|
10 |
8 |
p. 2109-2116
|
artikel
|
| 43 |
Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
|
Alenazy, Leila A.
|
|
|
10 |
8 |
p. 2169-2171.e2
|
artikel
|
Tijdschrift beschrijving